News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
28,257 Results
Type
Article (1042)
Company Profile (2)
Press Release (27213)
Section
Business (12670)
Career Advice (32)
Deals (1440)
Drug Delivery (1)
Drug Development (2447)
Employer Resources (1)
FDA (410)
Job Trends (563)
News (16256)
Policy (675)
Tag
Academia (33)
Allergies (3)
Alliances (1001)
ALS (2)
Alzheimer's disease (24)
Antibody-drug conjugate (ADC) (5)
Approvals (441)
Artificial intelligence (9)
Autoimmune disease (4)
Bankruptcy (8)
Best Places to Work (512)
Biosimilars (2)
Biotechnology (2)
Bladder cancer (8)
Brain cancer (1)
Breast cancer (20)
Cancer (168)
Cardiovascular disease (30)
Career advice (28)
CAR-T (6)
Cell therapy (15)
Cervical cancer (2)
Clinical research (2259)
Collaboration (17)
Compensation (14)
COVID-19 (73)
C-suite (19)
Cystic fibrosis (4)
Data (305)
Denatured (3)
Depression (4)
Diabetes (10)
Diagnostics (244)
Digital health (3)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (15)
Earnings (11769)
Employer resources (1)
Events (3518)
Executive appointments (11)
FDA (628)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (24)
Gene therapy (18)
GLP-1 (27)
Government (68)
Guidances (139)
Healthcare (593)
HIV (2)
IgA nephropathy (7)
Immunology and inflammation (5)
Indications (3)
Infectious disease (83)
Inflammatory bowel disease (9)
Influenza (7)
Intellectual property (7)
Interviews (8)
IPO (1061)
Job creations (89)
Job search strategy (24)
Labor market (1)
Layoffs (2)
Leadership (1)
Legal (146)
Liver cancer (3)
Lung cancer (44)
Lymphoma (17)
Manufacturing (9)
MASH (9)
Medical device (568)
Medtech (573)
Mergers & acquisitions (396)
Metabolic disorders (32)
Multiple sclerosis (9)
Neurodegenerative disease (6)
Neuropsychiatric disorders (5)
Neuroscience (66)
NextGen: Class of 2026 (181)
Non-profit (51)
Now hiring (2)
Obesity (10)
Opinion (2)
Ovarian cancer (4)
Pancreatic cancer (3)
Parkinson's disease (8)
Patents (5)
Patient recruitment (8)
People (873)
Pharmacy benefit managers (2)
Phase 1 (586)
Phase 2 (944)
Phase 3 (855)
Pipeline (517)
Postmarket research (101)
Preclinical (223)
Prostate cancer (3)
Radiopharmaceuticals (8)
Rare diseases (27)
Real estate (117)
Recruiting (1)
Regulatory (579)
Reports (3)
Research institute (34)
Resumes & cover letters (8)
Rett syndrome (3)
RSV (1)
Schizophrenia (5)
Series A (2)
Series B (4)
Sickle cell disease (4)
Spinal muscular atrophy (6)
Sponsored (1)
Startups (64)
Stomach cancer (1)
Vaccines (27)
Venture capital (2)
Weight loss (9)
Women's health (6)
Date
Last 7 days (21)
Last 30 days (57)
Last 365 days (1500)
2026 (69)
2025 (1507)
2024 (1727)
2023 (1967)
2022 (2887)
2021 (2033)
2020 (1635)
2019 (1129)
2018 (998)
2017 (708)
2016 (462)
2015 (796)
2014 (6336)
2013 (308)
2012 (387)
2011 (513)
2010 (487)
Location
Africa (31)
Alabama (3)
Arizona (8)
Asia (1526)
Australia (144)
California (489)
Canada (191)
China (36)
Colorado (22)
Connecticut (28)
Delaware (17)
Europe (3770)
Florida (72)
Georgia (24)
Illinois (47)
India (1)
Indiana (27)
Japan (18)
Kansas (2)
Kentucky (3)
Louisiana (6)
Maine (3)
Maryland (44)
Massachusetts (326)
Michigan (17)
Minnesota (25)
Missouri (4)
Montana (1)
Nevada (2)
New Hampshire (6)
New Jersey (179)
New York (157)
North Carolina (52)
Northern California (267)
Ohio (10)
Pennsylvania (130)
Puerto Rico (1)
South America (25)
Southern California (186)
Tennessee (31)
Texas (88)
United States (1905)
Utah (22)
Virginia (4)
Washington D.C. (3)
Washington State (68)
Wisconsin (6)
28,257 Results for "151".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MAIA Biotechnology Announces $1.51 Million Private Placement
December 17, 2025
·
4 min read
Press Releases
Axon Neuroscience’s Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant
February 4, 2026
·
6 min read
Press Releases
Single-use Bioprocessing Market Size to Surpass USD 151.48 Bn by 2034
October 30, 2025
·
1 min read
Philips completes cancellation of 15.1 million shares
Royal Philips announced that it has completed the cancellation of 15,134,054 of its shares.
December 19, 2023
·
1 min read
Press Releases
Progressive Pulmonary Fibrosis (PPF) Market Estimated to Reach USD 2,151.85 Million by 2034, Impelled by Advancements in Drug Development
August 5, 2024
·
12 min read
BioMidwest
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series A funding, co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations.
December 8, 2022
·
4 min read
Press Releases
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026
December 23, 2025
·
3 min read
Deals
Curis Announces $15.1 Million Registered Direct Offering
Curis, Inc. today announced that it has entered into definitive agreements led by existing investors for the purchase of 18.4 million of its shares of common stock at a purchase price of $0.82 per share in a registered direct offering priced at-the-market under Nasdaq rules.
July 6, 2023
·
5 min read
Medical Device Contract Research Organization Market Size to Surpass US$ 15.1 BN by 2030
The Medical Device Contract Research Organization Market size is expected to surpass around US$ 15.1 billion by 2030 from valued at US$ 7.3 billion in 2020 with a CAGR of 9.6% from 2021 to 2030.
April 26, 2022
·
6 min read
Epilepsy Therapeutics Market worth $ 15.1 Bn by 2030 at a CAGR of 4.5%
Latest Study on “Epilepsy Therapeutics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.
September 29, 2022
·
12 min read
1 of 2,826
Next
